Some combinations of these biomarkers such as HE4, osteopontin (OPN), and GDF-15 along with CA-125 seem promising, but still lack of sufficient sensitivity or specificity for early detection of recurrent ovarian cancer [6, 7, 9, 10, 12, 13, 24–28]. The gene discussed is SPP1; the disease is ovarian carcinoma.